| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |